Olmesartan-associated enteropathy: results of a national surveyLysiane Marthey, Franck Carbonnel, Guillaume Cadiot et al.|Alimentary Pharmacology & Therapeutics|2014Cited by 198
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative ColitisFranck Carbonnel, Gaëlle Brillaut, Gilles Bommelaer et al.|Gastroenterology|2015Cited by 144
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Émilie Del Tedesco, Maria Nachury et al.|Journal of Crohn s and Colitis|2020Cited by 35
Outcomes after double switching from originator Infliximab to biosimilar CT‐P13 and biosimilar SB2 in patients with inflammatory bowel disease: a 12‐month prospective cohort studyNoémie Trystram, Aurélien Amiot, Véred Abitbol et al.|Alimentary Pharmacology & Therapeutics|2021Cited by 30
Genetic Diagnosis Guides Treatment of Autoimmune EnteropathyFabienne Charbit‐Henrion, Luc Mouthon, Manon Haas et al.|Clinical Gastroenterology and Hepatology|2022Cited by 25